Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yung Shin Pharmaceutical Industrial (Kunshan) is a major pharmaceutical manufacturing subsidiary of the Taiwan-based Yung Shin Global Holding, located in Kunshan, China. Established in 1994, the company serves as a strategic manufacturing and commercial hub for the group's operations in mainland China. The company specializes in the production of a wide array of generic pharmaceutical products, including oral solids and liquid formulations. Its therapeutic focus includes cardiovascular diseases, gastrointestinal disorders, respiratory conditions, and infectious diseases. The Kunshan facility is built to international GMP standards, enabling the company to supply high-quality medicines to both domestic and international markets. In addition to finished dosage forms, the company is involved in the production of active pharmaceutical ingredients (APIs) and health supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yung Shin Pharmaceutical Industrial Kunshan.